Key Takeaway: Jennifer Cho has joined Immuneering as Associate Director, Clinical Scientist in 2026. With over ten years of experience in oncology clinical trials, she has worked on Phase I-III trials at companies like Novartis and Celgene. Her educational background includes a PharmD from the University of Maryland and a B.A. from Tufts University.
Price reaction · baseline $4.41 (2026-07-21T13:57:00.000Z) · hit during market hours · 2 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
+1.1%
Market Sentiment Analysis
POSITIVE FACTORS
Jennifer Cho brings over a decade of experience in oncology.
Her background includes significant roles at major pharmaceutical companies.
She has diverse experience in clinical trials and research.
Full Press Release Details
Jennifer joined Immuneering as Associate Director, Clinical Scientist in 2026. She has over a decade of experience in oncology clinical trials, with prior experience as a Clinical Scientist on Phase I-III trials at Novartis, Celgene, and Regeneron. Jennifer also has site experience as a Research Pharmacist at Jacobi Medical Center and as a Study Coordinator at Dana-Farber Cancer Institute, as well as vendor experience in clinical trial technology products (mobile eCOA and EDC). Jennifer earned her PharmD from the University of Maryland School of Pharmacy and her B.A. in Child Development and Community Health from Tufts University.
The post Jennifer Cho appeared first on Immuneering Corporation .
Frequently Asked Questions
What position did Jennifer Cho take at Immuneering?
Jennifer Cho joined Immuneering as Associate Director, Clinical Scientist.
How much experience does Jennifer Cho have in oncology?
Jennifer Cho has over a decade of experience in oncology clinical trials.
Where did Jennifer Cho earn her PharmD?
Jennifer earned her PharmD from the University of Maryland School of Pharmacy.
What companies did Jennifer work for before Immuneering?
Jennifer has worked at Novartis, Celgene, and Regeneron.